Mobilan

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMobilan
Drug Alias NameProstate cancer vaccine (Cleveland Biolabs)MVAME03M-VM3
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionToll like receptor 5 agonists
TargetsToll like receptor 5
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCleveland ClinicCleveland Biolabs IncChildren'S Cancer Research Institute +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPanacela Labs Llc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A